4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-048440
Chief Medical Officer sold 39,496 shares at $1.27 ($50,160)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HAMED KAMAL Chief Medical Officer | 2023-09-13 | Sale | −39,496 | $1.27 | $50,160 | 576,461 | D |
| Open-market sales · 39,496 sh · avg $1.27 · $50,160 | |||||||
Loading xslF345X05/ownership.xml…